Ch11: Bleeding and clotting disorders Flashcards
Hemostasis
process that prevents bleeding following injury involves a complex interaction of blood vessels, platelets, and chemical coagulation factors in plasma
blood vessels during hemostasis
undergo spastic contraction in response to injury aids by decreasing BF to area spasm of smooth muscle can occlude vascular lumen- stop bleeding. shunting of blood to other non-injured vessels provides circulation limiting injury to tissue
platelets during hemostasis
obstruct BF, promote vasoconstriction, release chemicals that further hemostatic process and facilitate clot retraction in healing phase. platelets stick to surface=adhesion adhesion + aggregation of platelets to each other as they form a platelet plug (plug may be sufficient alone for hemostasis in small vessels)
blood coagulation/clotting
process of plasma from a liquid to a solid fibrinogen -> fibrin (stringy, strong, insoluble protein thrombus
coagulation/clotting cascade
formation of fibrin happens through a series of enzymatic steps the product of each step catalyzes and augments the next step. reaction can slow/stop by inhibitors 2 enzymes: thrombin and factor XIII
thrombus
blood clot- contains fibrin with entrapped RBCs and platelets
thrombosis
clotting in a blood vessel
organized thrombus
thrombus converted into scar tissue
virchow’s triad
1: endothelial cell injury 2: stasis or turbulence of BF 3: hyper-coagulability
pulmonary embolism
thrombus forms in vein, dislodges and gets stuck in pulmonary arteries
thrombocytopenia
decreased number of circulating platelets includes bone marrow failure and peripheral destruction of platelets spontaneous bleeding may be anticipated when the platelet count drops below 10,000 mcL or when platelets are defective
petechiae
small hemorrhages
epistaxis
nose bleeds
hematuria
blood in urine
hematochezia
fecal blood
menorrhagia
excessive menstrual bleeding
hematoma
localized collection of blood
purpura
blood in skin
disseminated intravascular coagulation (DIC)
serious condition in critically ill patients develop fibrin thrombi in small vessels throughout the body, and at the same time bleed extensively throughout vessels. simultaneous clotting and bleeding makes it difficult to treat
hemorrhagic diathesis
pt with a tendency to bleed
coagulopathy
abnormality in the coagulation mechanism leading to either excessive bleeding or excessive clotting
tests
- Platelet count: 150,000-400,000
- Bleeding time: no longer used
- Platelet function analyzer (PFA 100)
- Activated partial thromboplastin time (aPTT)
- Prothrombin time (PT)
- D-dimer
PFA
measures platelet dependent coagulation under flow conditions
PTT
blood sample drawn, add calcium- activates coagulation system- 30s normal, measures heparin effectiveness